Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: Manufacturing sources and transplacental transfer

Environmental Health Perspectives

Volumn 119, Issue 11, 2011, Pages 1659-1664

  Beesoon, Sanjay ^a   Webster, Glenys M ^b   Shoeib, Mahiba ^c   Harner, Tom ^c   Benskin, Jonathan P ^a   Martin, Jonathan W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ENVIRONMENT CANADA   (Canada)

Author keywords

Isomers; Perfluorochemicals; PFOA; PFOS; Transplacental transfer

Indexed keywords

PERFLUORO COMPOUND; PERFLUOROOCTANE; PERFLUOROOCTANESULFONIC ACID;

ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DELIVERY; DIETARY INTAKE; ELECTROCHEMICAL ANALYSIS; ENVIRONMENTAL EXPOSURE; EXPLORATORY RESEARCH; FEMALE; FLUORINATION; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOUSE DUST; HOUSEHOLD; HUMAN; ISOMER; MATERNAL BLOOD; MOTHER FETUS RELATIONSHIP; PLACENTAL TRANSFER; PREGNANT WOMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UMBILICAL CORD BLOOD;

ALKANESULFONIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DUST; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL BLOOD; FLUOROCARBONS; HUMANS; MATERNAL-FETAL EXCHANGE; OCTANOIC ACIDS; PREGNANCY; TANDEM MASS SPECTROMETRY;

RODENTIA;

EID: 80455144492     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1003265     Document Type: Article

References (44)

1. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. 2007. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115:1670-1676.
2. Benskin JP, Bataineh M, Martin JW. 2007. Simultaneous characterization of perfluoroalkyl carboxylate, sulfonate, and sulfonamide isomers by liquid chromatography-tandem mass spectrometry. Anal Chem 79(17):6455-6464.
3. Benskin JP, Holt A, Martin JW. 2009. Isomer-specific biotransformation rates of a perfluorooctane sulfonate (PFOS)-precursor by cytochrome P450 isozymes and human liver microsomes. Environ Sci Technol 43(22):8566-8572.
4. Bjorklund JA, Thuresson K, De Wit CA. 2009. Perfluoroalkyl compounds (PFCs) in indoor dust: concentrations, human exposure estimates, and sources. Environ Sci Technol 43(7):2276-2281.
5. Butte W, Heinzow B. 2002. Pollutants in house dust as indicators of indoor contamination. Rev Environ Contam Toxicol 175:1-46.
6. D'eon JC, Mabury SA. 2011. Exploring indirect sources of human exposure to perfluoroalkyl carboxylates (PFCAs): evaluating uptake, elimination, and biotransformation of polyfluoroalkyl phosphate esters (PAPs) in the rat. Environ Health Perspect 119:344-350.
7. De Silva AO, Benskin JP, Martin LJ, Arsenault G, McCrindle R, Riddell N, et al. 2009. Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 2: subchronic dose. Environ Toxicol Chem 28(3):555-567.
8. De Silva AO, Mabury SA. 2006. Isomer distribution of perfluorocarboxylates in human blood: potential correlation to source. Environ Sci Technol 40(9):2903-2909.
9. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish national birth cohort. Environ Health Perspect 115:1677-1678.
10. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2008. Fetal growth indicators and perfluorinated chemicals: a study in the Danish national birth cohort. Am J Epidemiol 168(1):66-72.
11. Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, et al. 2010. Pre-and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 44(18):7123-7129.
12. Goosey E, Harrad S. 2011. Perfluoroalkyl compounds in dust from Asian, Australian, European, and North American homes and UK cars, classrooms, and offices. Environ Int 37:86-92.
13. Hanssen L, Rollin H, Odland JO, Moe MK, Sandanger TM. 2010. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study. J Environ Monitor 12(6):1355-1361.
14. Haug L, Huber S, Becher G, Thomsen C. 2011. Characterization of human exposure pathways to perfluorinated compounds-comparing exposure estimates with biomarkers of exposure. Environ Int 37(4):687-693.
15. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204-1207.
16. Jones PD, Hu W, De Coen W, Newsted JL, Giesy JP. 2003. Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem 22(11):2639-2649.
17. Karrman A, Langlois I, van Bavel B, Lindstrom G, Oehme M. 2007. Identification and pattern of perfluorooctane sulfonate (PFOS) isomers in human serum and plasma. Environ Int 33(6):782-788.
18. Kato K, Calafat AM, Needham LL. 2009. Polyfluoroalkyl chemicals in house dust. Environ Res 109(5):518-523.
19. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 45(19):8037-9045.
20. Kim SK, Lee KT, Kang CS, Tao L, Kannan K, Kim KR, et al. 2011. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ Pollut 159(1):169-174.
21. Kissa E. 1994. Fluorinated Surfactants. New York:Marcel Dekker.
22. Kubwabo C, Stewart B, Zhu JP, Marro L. 2005. Occurrence of perfluorosulfonates and other perfluorochemicals in dust from selected homes in the city of Ottawa, Canada. J Environ Monit 7(11):1074-1078.
23. Kuklenyik Z, Reich JA, Tully JS, Needham LL, Calafat AM. 2004. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol 38 (13):3698-3704.
24. Langlois I, Oehme M. 2006. Structural identification of isomers present in technical perfluorooctane sulfonate by tandem mass spectrometry. Rapid Commun Mass Spectrom 20(5):844-850.
25. Lau C, Butenhoff JL, Rogers JM. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231-241.
26. Loveless SE, Finlay C, Everds NE, Frame SR, Gillies PJ, O'Connor JC, et al. 2006. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 220(2-3):203-217.
27. Martin JW, Asher BJ, Beesoon S, Benskin JP, Ross MS. 2010. PFOS or PreFOS? Are perfluorooctane sulfonate precursors (PreFOS) important determinants of human and environmental perfluorooctane sulfonate (PFOS) exposure? J Environ Monit 12:1979-2004.
28. Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J. 2007. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80(7):643-648.
29. Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B, et al. 2008. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108(1):56-62.
30. Needham LL, Grandjean P, Heinzow B, Jørgensen PJ, Nielsen F, Patterson DG Jr. 2011. Partition of environmental chemicals between maternal and fetal blood and tissues. Environ Sci Technol 45(3):1121-1126.
31. Nelson JW, Hatch EE, Webster TF. 2010. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general US population. Environ Health Perspect 118:197-202.
32. Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmett EA. 2009. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27:231-238.
33. Olsen GW, Mair DC, Church TR, Ellefson ME, Reagen WK, Boyd TM, et al. 2008. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 42(13):4989-4995.
34. Paul AG, Jones KC, Sweetman AJ. 2009. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol 43(2):386-392.
35. Shoeib M, Harner T, Webster G, Lee S. 2011. Indoor sources of poly-and perfluorinated compounds (PFCs) in Vancouver, Canada: implications for human exposure. Environ Sci Technol 45(19):7999-8005.
36. Steenland K, Tinker S, Shankar A, Ducatman A. 2010. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect 118:229-233.
37. Strynar MJ, Lindstrom AB. 2008. Perfluorinated compounds in house dust from Ohio and North Carolina, USA. Environ Sci Technol 42(10):3751-3756.
38. Syme MR, Paxton JW, Keelan JA. 2004. Drug transfer and metabolism by the human placenta. Clin Pharmocokinet 43(8):487-514.
39. Tittlemier SA, Pepper K, Seymour C, Moisey J, Bronson R, Cao X-L, et al. 2007. Dietary exposure of Canadians to perfluorocarboxylates and perfluorooctanesulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem 55(8):3203-3210.
40. U.S. EPA (U.S. Environmental Protection Agency). 2006. 2010/2015 PFOA Stewardship Program. Available: http://www.epa.gov/oppt/pfoa/pubs/stewardship/index.html [accessed 23 March 2011].
41. U.S. EPA (U.S. Environmental Protection Agency). 2008. Child-Specific Exposure Factors Handbook (Final Report). EPA/600/R-06/096F. Washington, DC:U.S. EPA.
42. Van der Aa EM, Peereboom-Stegman JHJC, Noordhoek J, Gribnau FWJ, Russel FGM. 1998. Mechanisms of drug transfer across the human placenta. Pharm World Sci 20(4):139-148.
43. Webster GM, Teshchke K, Janssen PA. 2011. Recruitment of healthy first-trimester pregnant women: lessons from the Chemicals, Health and Pregnancy study (CHirP). Matern Child Health J; doi:10.1007/s10995-010-0739-8 [Online 6 January 2011].
44. Whittaker PG, MacPhail S, Lind T. 1996. Serial hematologic changes and pregnancy outcome. Obstet Gynecol 88(1):33-39.